GSK seeks U.S. approval for shingles vaccine Shingrix
October 24, 2016 at 02:17 AM EDT
LONDON, Oct 24 (Reuters) - GlaxoSmithKline said on Monday it had filed its shingles vaccine Shingrix for U.S. regulatory approval, bringing the potential blockbuster a step closer to market.
